Invesco Biotechnology & Genome ETF
PBE
#2031
ETF rank
HK$2.04 B
Marketcap
๐Ÿ‡บ๐Ÿ‡ธ US
Market
HK$639.99
Share price
-1.02%
Change (1 day)
22.23%
Change (1 year)

Invesco Biotechnology & Genome ETF - Holdings

Etf holdings as of February 9, 2026

Number of holdings: 32

Full holdings list

Weight %NameTickerShares Held
5.92%
Gilead Sciences IncGILD103447
5.49%
Amgen IncAMGN38764
5.36%
Biogen IncBIIB73288
5.02%
Incyte CorpINCY121977
5.01%
Regeneron Pharmaceuticals IncREGN17019
4.85%
United Therapeutics CorpUTHR27156
4.55%
Illumina IncILMN102881
3.85%
Amicus Therapeutics IncFOLD714706
3.61%
Dynavax Technologies CorpDVAX617872
3.60%
Alnylam Pharmaceuticals IncALNY29843
3.07%
MannKind CorpMNKD1377865
2.95%
Royalty Pharma PLCRPRX177823
2.90%
Halozyme Therapeutics IncHALO95519
2.88%
Ionis Pharmaceuticals IncIONS90021
2.87%
QIAGEN NVQGEN149733.3786
2.78%
BioMarin Pharmaceutical IncBMRN127360
2.77%
Exelixis IncEXEL167301
2.77%
Catalyst Pharmaceuticals IncCPRX300657
2.75%
Bio-Techne CorpTECH111332
2.71%
Collegium Pharmaceutical IncCOLL155095
2.63%
Neurocrine Biosciences IncNBIX50042
2.59%
ACADIA Pharmaceuticals IncACAD295751
2.53%
Protagonist Therapeutics IncPTGX80607
2.48%
PTC Therapeutics IncPTCT88544
2.46%
TG Therapeutics IncTGTX220683
2.46%
BioCryst Pharmaceuticals IncBCRX1034912
2.43%
Vericel CorpVCEL181802
2.29%
Repligen CorpRGEN42260
2.21%
Madrigal Pharmaceuticals IncMDGL12023
2.10%
Veracyte IncVCYT151359
0.07%
Invesco Government & Agency PortfolioAGPXX189645.2
0.03%
CASH & EQUIVALENTSUSD84861.56